

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.21979501 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.91053992 |
| 3 | locomotory exploration behavior (GO:0035641) | 5.81579131 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 5.65200483 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.64940283 |
| 6 | glutamate secretion (GO:0014047) | 5.45525670 |
| 7 | vocalization behavior (GO:0071625) | 5.43475644 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.25739079 |
| 9 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.22230269 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.19103017 |
| 11 | regulation of glutamate receptor signaling pathway (GO:1900449) | 5.00593790 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.99742146 |
| 13 | protein localization to synapse (GO:0035418) | 4.93191521 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.61735847 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.60219890 |
| 16 | exploration behavior (GO:0035640) | 4.53910145 |
| 17 | regulation of synaptic vesicle transport (GO:1902803) | 4.48080578 |
| 18 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.46913938 |
| 19 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.44225659 |
| 20 | neurotransmitter secretion (GO:0007269) | 4.43435060 |
| 21 | cellular potassium ion homeostasis (GO:0030007) | 4.43363326 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.41398093 |
| 23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.29737564 |
| 24 | neuron cell-cell adhesion (GO:0007158) | 4.28470239 |
| 25 | layer formation in cerebral cortex (GO:0021819) | 4.27071449 |
| 26 | glutamate receptor signaling pathway (GO:0007215) | 4.23891546 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 4.22520494 |
| 28 | presynaptic membrane organization (GO:0097090) | 4.20038950 |
| 29 | regulation of synapse structural plasticity (GO:0051823) | 4.13630154 |
| 30 | long-term memory (GO:0007616) | 4.13157473 |
| 31 | central nervous system myelination (GO:0022010) | 4.04981956 |
| 32 | axon ensheathment in central nervous system (GO:0032291) | 4.04981956 |
| 33 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.04922169 |
| 34 | sodium ion export (GO:0071436) | 3.98570872 |
| 35 | neuron-neuron synaptic transmission (GO:0007270) | 3.92365009 |
| 36 | proline transport (GO:0015824) | 3.90005043 |
| 37 | positive regulation of synapse maturation (GO:0090129) | 3.87061499 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.78829460 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.76566600 |
| 40 | neuromuscular synaptic transmission (GO:0007274) | 3.74422971 |
| 41 | positive regulation of membrane potential (GO:0045838) | 3.73850284 |
| 42 | synaptic vesicle endocytosis (GO:0048488) | 3.70315707 |
| 43 | gamma-aminobutyric acid transport (GO:0015812) | 3.69156801 |
| 44 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.61854195 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.61679923 |
| 46 | regulation of postsynaptic membrane potential (GO:0060078) | 3.60886800 |
| 47 | regulation of synaptic plasticity (GO:0048167) | 3.60672477 |
| 48 | neurotransmitter transport (GO:0006836) | 3.59776800 |
| 49 | long-term synaptic potentiation (GO:0060291) | 3.59093213 |
| 50 | behavioral response to nicotine (GO:0035095) | 3.54186708 |
| 51 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.48719678 |
| 52 | cell communication by electrical coupling (GO:0010644) | 3.48640879 |
| 53 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.46923058 |
| 54 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.45872677 |
| 55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.45755360 |
| 56 | neuron recognition (GO:0008038) | 3.43817159 |
| 57 | neuronal ion channel clustering (GO:0045161) | 3.43255650 |
| 58 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.42725960 |
| 59 | regulation of neurotransmitter secretion (GO:0046928) | 3.41923721 |
| 60 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.40148698 |
| 61 | L-amino acid import (GO:0043092) | 3.39545442 |
| 62 | neurotransmitter uptake (GO:0001504) | 3.33018897 |
| 63 | regulation of neurotransmitter levels (GO:0001505) | 3.32931286 |
| 64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.31559435 |
| 65 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.30108369 |
| 66 | postsynaptic membrane organization (GO:0001941) | 3.29135642 |
| 67 | axonal fasciculation (GO:0007413) | 3.28231242 |
| 68 | regulation of vesicle fusion (GO:0031338) | 3.28085165 |
| 69 | response to auditory stimulus (GO:0010996) | 3.27930304 |
| 70 | transmission of nerve impulse (GO:0019226) | 3.26771909 |
| 71 | neuromuscular process controlling balance (GO:0050885) | 3.22484350 |
| 72 | response to histamine (GO:0034776) | 3.21371282 |
| 73 | innervation (GO:0060384) | 3.21212522 |
| 74 | potassium ion import (GO:0010107) | 3.20179386 |
| 75 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.19370716 |
| 76 | regulation of neurotransmitter transport (GO:0051588) | 3.16959752 |
| 77 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.14935464 |
| 78 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.14734383 |
| 79 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.13251522 |
| 80 | behavioral defense response (GO:0002209) | 3.13106445 |
| 81 | behavioral fear response (GO:0001662) | 3.13106445 |
| 82 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.12454595 |
| 83 | auditory behavior (GO:0031223) | 3.10834546 |
| 84 | positive regulation of synaptic transmission (GO:0050806) | 3.10504925 |
| 85 | membrane depolarization during action potential (GO:0086010) | 3.10082651 |
| 86 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08584069 |
| 87 | regulation of dendritic spine development (GO:0060998) | 3.08018220 |
| 88 | adult walking behavior (GO:0007628) | 3.07805501 |
| 89 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.07707860 |
| 90 | membrane depolarization (GO:0051899) | 3.07226462 |
| 91 | neuromuscular process controlling posture (GO:0050884) | 3.06721100 |
| 92 | positive regulation of dendritic spine development (GO:0060999) | 3.06382706 |
| 93 | * activation of protein kinase A activity (GO:0034199) | 3.05582909 |
| 94 | C4-dicarboxylate transport (GO:0015740) | 3.05161368 |
| 95 | regulation of synaptic transmission (GO:0050804) | 3.03451340 |
| 96 | learning (GO:0007612) | 3.03159043 |
| 97 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02579061 |
| 98 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.01265020 |
| 99 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.99801686 |
| 100 | regulation of synapse maturation (GO:0090128) | 2.99352634 |
| 101 | * synaptic transmission (GO:0007268) | 2.96201981 |
| 102 | fear response (GO:0042596) | 2.96135746 |
| 103 | membrane hyperpolarization (GO:0060081) | 2.95547169 |
| 104 | dendrite morphogenesis (GO:0048813) | 2.95319519 |
| 105 | presynaptic membrane assembly (GO:0097105) | 2.94901157 |
| 106 | amino acid import (GO:0043090) | 2.94379987 |
| 107 | cellular sodium ion homeostasis (GO:0006883) | 2.92720511 |
| 108 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.90825534 |
| 109 | cerebellar granule cell differentiation (GO:0021707) | 2.89658332 |
| 110 | acidic amino acid transport (GO:0015800) | 2.89394741 |
| 111 | intraspecies interaction between organisms (GO:0051703) | 2.88659342 |
| 112 | social behavior (GO:0035176) | 2.88659342 |
| 113 | synapse assembly (GO:0007416) | 2.88483134 |
| 114 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.87095653 |
| 115 | regulation of membrane repolarization (GO:0060306) | 2.86881906 |
| 116 | potassium ion homeostasis (GO:0055075) | 2.86262231 |
| 117 | neurofilament cytoskeleton organization (GO:0060052) | 2.83440499 |
| 118 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.79245486 |
| 119 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.75611885 |
| 120 | regulation of cell communication by electrical coupling (GO:0010649) | 2.75590847 |
| 121 | serotonin metabolic process (GO:0042428) | 2.74650278 |
| 122 | startle response (GO:0001964) | 2.74358766 |
| 123 | regulation of neurotransmitter uptake (GO:0051580) | 2.73100799 |
| 124 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.73066981 |
| 125 | multicellular organismal signaling (GO:0035637) | 2.69904611 |
| 126 | L-glutamate transport (GO:0015813) | 2.69763395 |
| 127 | regulation of respiratory system process (GO:0044065) | 2.66118408 |
| 128 | retinal cone cell development (GO:0046549) | 2.65947997 |
| 129 | neuronal action potential (GO:0019228) | 2.64748363 |
| 130 | nucleobase catabolic process (GO:0046113) | 2.63394917 |
| 131 | cell differentiation in hindbrain (GO:0021533) | 2.62905362 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.03290398 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.45602448 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.18711283 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.13733497 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.09880664 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.79834115 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.79834115 |
| 8 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.73221289 |
| 9 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.68384801 |
| 10 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.67279832 |
| 11 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.63599469 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.58797367 |
| 13 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.56954648 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.56129582 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.51396895 |
| 16 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.51287482 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.50175170 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.41119000 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27168500 |
| 20 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.25533577 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21995443 |
| 22 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.21095873 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18038692 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.10250501 |
| 25 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.01235613 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.86652468 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.85935927 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.81649368 |
| 29 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.77798803 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77393943 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74006909 |
| 32 | VDR_22108803_ChIP-Seq_LS180_Human | 1.73861183 |
| 33 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.73585809 |
| 34 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.66585179 |
| 35 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.62007764 |
| 36 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.61914108 |
| 37 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.60550203 |
| 38 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60064582 |
| 39 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.45590556 |
| 40 | * TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.42799364 |
| 41 | * POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.42799364 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41749113 |
| 43 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.41016471 |
| 44 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37205690 |
| 45 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34273693 |
| 46 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33032769 |
| 47 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.32767119 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32200452 |
| 49 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.30814877 |
| 50 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30533182 |
| 51 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.29860101 |
| 52 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28931752 |
| 53 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.28087039 |
| 54 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.27969791 |
| 55 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.27280914 |
| 56 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.26856126 |
| 57 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26548595 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.23483451 |
| 59 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.22661124 |
| 60 | * AR_19668381_ChIP-Seq_PC3_Human | 1.22562735 |
| 61 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.22401480 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.22241820 |
| 63 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.19665063 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16655883 |
| 65 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15153333 |
| 66 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15015109 |
| 67 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14869723 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14523835 |
| 69 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13728474 |
| 70 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09958887 |
| 71 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09640293 |
| 72 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09364104 |
| 73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08303151 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08103182 |
| 75 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07745742 |
| 76 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07541023 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.07417317 |
| 78 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.06392267 |
| 79 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05652077 |
| 80 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05355863 |
| 81 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05355863 |
| 82 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05237306 |
| 83 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.05199055 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.04670997 |
| 85 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.04134700 |
| 86 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03888987 |
| 87 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02939722 |
| 88 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02907284 |
| 89 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02342258 |
| 90 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.02039883 |
| 91 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.01986858 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01417814 |
| 93 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00342867 |
| 94 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99916832 |
| 95 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.99575529 |
| 96 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.97500287 |
| 97 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.97456790 |
| 98 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97241219 |
| 99 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97099567 |
| 100 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95843964 |
| 101 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.95268258 |
| 102 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94711488 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94489797 |
| 104 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93581052 |
| 105 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93316736 |
| 106 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.92992002 |
| 107 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.92834595 |
| 108 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.92551661 |
| 109 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90439285 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.89872494 |
| 111 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.89224885 |
| 112 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89054351 |
| 113 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.87635913 |
| 114 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.87388352 |
| 115 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.86137739 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85433096 |
| 117 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85362577 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.84800318 |
| 119 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84440034 |
| 120 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.84337141 |
| 121 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.83998648 |
| 122 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.82109441 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.74286101 |
| 2 | MP0003880_abnormal_central_pattern | 4.71798684 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.18696465 |
| 4 | MP0004270_analgesia | 3.74358124 |
| 5 | MP0009745_abnormal_behavioral_response | 3.39939904 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.35699446 |
| 7 | MP0002064_seizures | 3.17449479 |
| 8 | MP0009046_muscle_twitch | 2.99049972 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.95482262 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.80133870 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.74007607 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.65435464 |
| 13 | MP0001486_abnormal_startle_reflex | 2.62270092 |
| 14 | MP0002272_abnormal_nervous_system | 2.56170862 |
| 15 | MP0002822_catalepsy | 2.52448367 |
| 16 | MP0002736_abnormal_nociception_after | 2.35128947 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.31740643 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.11236836 |
| 19 | MP0001440_abnormal_grooming_behavior | 2.05577487 |
| 20 | MP0002735_abnormal_chemical_nociception | 1.99743273 |
| 21 | MP0004858_abnormal_nervous_system | 1.99691705 |
| 22 | MP0002067_abnormal_sensory_capabilities | 1.91155644 |
| 23 | MP0008569_lethality_at_weaning | 1.90831102 |
| 24 | MP0001970_abnormal_pain_threshold | 1.85704912 |
| 25 | MP0003329_amyloid_beta_deposits | 1.84241924 |
| 26 | MP0003136_yellow_coat_color | 1.82669744 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.81990677 |
| 28 | MP0005646_abnormal_pituitary_gland | 1.79552687 |
| 29 | MP0002184_abnormal_innervation | 1.68258312 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.68152323 |
| 31 | MP0002557_abnormal_social/conspecific_i | 1.67256371 |
| 32 | MP0004811_abnormal_neuron_physiology | 1.67251866 |
| 33 | MP0003879_abnormal_hair_cell | 1.66088349 |
| 34 | MP0000778_abnormal_nervous_system | 1.62512187 |
| 35 | MP0008877_abnormal_DNA_methylation | 1.61698052 |
| 36 | MP0001984_abnormal_olfaction | 1.61067162 |
| 37 | MP0005386_behavior/neurological_phenoty | 1.58818620 |
| 38 | MP0004924_abnormal_behavior | 1.58818620 |
| 39 | MP0000751_myopathy | 1.58015735 |
| 40 | MP0000955_abnormal_spinal_cord | 1.50534593 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.50245355 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.44664614 |
| 43 | MP0004885_abnormal_endolymph | 1.44193483 |
| 44 | MP0002882_abnormal_neuron_morphology | 1.43885410 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.40024220 |
| 46 | MP0003787_abnormal_imprinting | 1.39730686 |
| 47 | MP0000749_muscle_degeneration | 1.39122956 |
| 48 | MP0002066_abnormal_motor_capabilities/c | 1.37996264 |
| 49 | MP0003633_abnormal_nervous_system | 1.35766990 |
| 50 | MP0004145_abnormal_muscle_electrophysio | 1.32078230 |
| 51 | MP0003122_maternal_imprinting | 1.31175104 |
| 52 | MP0002653_abnormal_ependyma_morphology | 1.28745057 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.25083163 |
| 54 | MP0003890_abnormal_embryonic-extraembry | 1.19524323 |
| 55 | MP0004142_abnormal_muscle_tone | 1.17662581 |
| 56 | MP0003631_nervous_system_phenotype | 1.13538491 |
| 57 | MP0003075_altered_response_to | 1.13395032 |
| 58 | MP0001905_abnormal_dopamine_level | 1.12395564 |
| 59 | MP0004233_abnormal_muscle_weight | 1.10703723 |
| 60 | MP0001529_abnormal_vocalization | 1.08443071 |
| 61 | MP0002152_abnormal_brain_morphology | 1.05970428 |
| 62 | MP0002090_abnormal_vision | 1.05629100 |
| 63 | MP0010386_abnormal_urinary_bladder | 1.04256358 |
| 64 | MP0004133_heterotaxia | 1.02925558 |
| 65 | MP0004043_abnormal_pH_regulation | 1.00912393 |
| 66 | MP0002229_neurodegeneration | 0.98246359 |
| 67 | MP0003121_genomic_imprinting | 0.98072518 |
| 68 | MP0002102_abnormal_ear_morphology | 0.95634683 |
| 69 | MP0003690_abnormal_glial_cell | 0.94304842 |
| 70 | MP0004036_abnormal_muscle_relaxation | 0.93518700 |
| 71 | MP0008872_abnormal_physiological_respon | 0.93385556 |
| 72 | MP0005377_hearing/vestibular/ear_phenot | 0.93369895 |
| 73 | MP0003878_abnormal_ear_physiology | 0.93369895 |
| 74 | MP0001986_abnormal_taste_sensitivity | 0.93291181 |
| 75 | MP0002069_abnormal_eating/drinking_beha | 0.91415602 |
| 76 | MP0004147_increased_porphyrin_level | 0.91260903 |
| 77 | MP0001177_atelectasis | 0.90432643 |
| 78 | MP0003634_abnormal_glial_cell | 0.90205016 |
| 79 | MP0003646_muscle_fatigue | 0.89020935 |
| 80 | MP0005394_taste/olfaction_phenotype | 0.88523974 |
| 81 | MP0005499_abnormal_olfactory_system | 0.88523974 |
| 82 | MP0000013_abnormal_adipose_tissue | 0.87451860 |
| 83 | MP0000026_abnormal_inner_ear | 0.83726957 |
| 84 | MP0003119_abnormal_digestive_system | 0.83690934 |
| 85 | MP0008874_decreased_physiological_sensi | 0.83211889 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.82881140 |
| 87 | MP0002752_abnormal_somatic_nervous | 0.80678161 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.80602382 |
| 89 | MP0005535_abnormal_body_temperature | 0.80030796 |
| 90 | MP0000604_amyloidosis | 0.79171738 |
| 91 | MP0004215_abnormal_myocardial_fiber | 0.78893730 |
| 92 | MP0003632_abnormal_nervous_system | 0.78721171 |
| 93 | MP0002837_dystrophic_cardiac_calcinosis | 0.78645123 |
| 94 | MP0003861_abnormal_nervous_system | 0.78359380 |
| 95 | MP0002106_abnormal_muscle_physiology | 0.77995778 |
| 96 | MP0004085_abnormal_heartbeat | 0.77800003 |
| 97 | MP0002638_abnormal_pupillary_reflex | 0.77396307 |
| 98 | MP0001188_hyperpigmentation | 0.76155144 |
| 99 | MP0000579_abnormal_nail_morphology | 0.74652636 |
| 100 | MP0006072_abnormal_retinal_apoptosis | 0.74393221 |
| 101 | MP0004484_altered_response_of | 0.73637325 |
| 102 | MP0000631_abnormal_neuroendocrine_gland | 0.73090564 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.69382129 |
| 104 | MP0000920_abnormal_myelination | 0.64798557 |
| 105 | MP0005253_abnormal_eye_physiology | 0.64684863 |
| 106 | MP0004742_abnormal_vestibular_system | 0.64473676 |
| 107 | MP0004130_abnormal_muscle_cell | 0.62856490 |
| 108 | MP0001664_abnormal_digestion | 0.62854632 |
| 109 | MP0003137_abnormal_impulse_conducting | 0.62755383 |
| 110 | MP0000747_muscle_weakness | 0.61456688 |
| 111 | MP0004510_myositis | 0.61453801 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.61119952 |
| 113 | MP0001299_abnormal_eye_distance/ | 0.60299607 |
| 114 | MP0003283_abnormal_digestive_organ | 0.59902286 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.58123843 |
| 116 | MP0001943_abnormal_respiration | 0.57558992 |
| 117 | MP0005620_abnormal_muscle_contractility | 0.57483724 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.57297007 |
| 119 | MP0003123_paternal_imprinting | 0.54236953 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.94849734 |
| 2 | Myokymia (HP:0002411) | 6.81252465 |
| 3 | Focal seizures (HP:0007359) | 5.61687446 |
| 4 | Visual hallucinations (HP:0002367) | 5.25318028 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.18765883 |
| 6 | Atonic seizures (HP:0010819) | 4.62201331 |
| 7 | Febrile seizures (HP:0002373) | 4.44834764 |
| 8 | Absence seizures (HP:0002121) | 4.31712844 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.17362738 |
| 10 | Generalized tonic-clonic seizures (HP:0002069) | 4.08438374 |
| 11 | Dialeptic seizures (HP:0011146) | 3.94904099 |
| 12 | Action tremor (HP:0002345) | 3.79718418 |
| 13 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.63669506 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 3.57415420 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.42121613 |
| 16 | Nemaline bodies (HP:0003798) | 3.41847661 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.38869040 |
| 18 | Broad-based gait (HP:0002136) | 3.35285388 |
| 19 | Ankle clonus (HP:0011448) | 3.32087549 |
| 20 | Depression (HP:0000716) | 3.24641120 |
| 21 | Dysdiadochokinesis (HP:0002075) | 3.24080039 |
| 22 | Hyperventilation (HP:0002883) | 3.18847002 |
| 23 | Exercise-induced muscle cramps (HP:0003710) | 3.14238227 |
| 24 | Poor eye contact (HP:0000817) | 3.10314838 |
| 25 | Gaze-evoked nystagmus (HP:0000640) | 3.09117045 |
| 26 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.07444085 |
| 27 | Dysmetria (HP:0001310) | 3.03577669 |
| 28 | Postural instability (HP:0002172) | 2.99468014 |
| 29 | Truncal ataxia (HP:0002078) | 2.96226903 |
| 30 | Abnormal eating behavior (HP:0100738) | 2.93655407 |
| 31 | Anxiety (HP:0000739) | 2.90681147 |
| 32 | Hemiparesis (HP:0001269) | 2.87408278 |
| 33 | Abnormal social behavior (HP:0012433) | 2.86555544 |
| 34 | Impaired social interactions (HP:0000735) | 2.86555544 |
| 35 | Megalencephaly (HP:0001355) | 2.86010224 |
| 36 | Amblyopia (HP:0000646) | 2.82899243 |
| 37 | Abnormality of the lower motor neuron (HP:0002366) | 2.78972513 |
| 38 | Limb dystonia (HP:0002451) | 2.71689463 |
| 39 | Abnormality of binocular vision (HP:0011514) | 2.69297311 |
| 40 | Diplopia (HP:0000651) | 2.69297311 |
| 41 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.68091958 |
| 42 | Hemiplegia (HP:0002301) | 2.66430019 |
| 43 | Mutism (HP:0002300) | 2.66112950 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.63966111 |
| 45 | Cerebral inclusion bodies (HP:0100314) | 2.62600210 |
| 46 | Urinary urgency (HP:0000012) | 2.60535245 |
| 47 | Excessive salivation (HP:0003781) | 2.56808587 |
| 48 | Drooling (HP:0002307) | 2.56808587 |
| 49 | Calf muscle hypertrophy (HP:0008981) | 2.53433348 |
| 50 | Myotonia (HP:0002486) | 2.51496559 |
| 51 | Bradykinesia (HP:0002067) | 2.50896687 |
| 52 | Genetic anticipation (HP:0003743) | 2.50406385 |
| 53 | Epileptiform EEG discharges (HP:0011182) | 2.48463448 |
| 54 | Torticollis (HP:0000473) | 2.47981035 |
| 55 | Fetal akinesia sequence (HP:0001989) | 2.46809421 |
| 56 | Status epilepticus (HP:0002133) | 2.44345592 |
| 57 | Exercise-induced myalgia (HP:0003738) | 2.44107394 |
| 58 | Impaired vibratory sensation (HP:0002495) | 2.42841960 |
| 59 | Papilledema (HP:0001085) | 2.41766397 |
| 60 | Pancreatic fibrosis (HP:0100732) | 2.39849990 |
| 61 | Impaired smooth pursuit (HP:0007772) | 2.39791491 |
| 62 | Abnormality of the labia minora (HP:0012880) | 2.38353676 |
| 63 | EEG with generalized epileptiform discharges (HP:0011198) | 2.36707001 |
| 64 | Focal dystonia (HP:0004373) | 2.33627928 |
| 65 | Spastic gait (HP:0002064) | 2.30531244 |
| 66 | Abnormality of the corticospinal tract (HP:0002492) | 2.25467972 |
| 67 | Progressive inability to walk (HP:0002505) | 2.24680763 |
| 68 | Ventricular fibrillation (HP:0001663) | 2.23805692 |
| 69 | Scanning speech (HP:0002168) | 2.23450781 |
| 70 | Aplasia of the phalanges of the hand (HP:0009802) | 2.23314441 |
| 71 | Aplasia involving bones of the extremities (HP:0009825) | 2.23314441 |
| 72 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.23314441 |
| 73 | Polyphagia (HP:0002591) | 2.22614017 |
| 74 | Intention tremor (HP:0002080) | 2.21123092 |
| 75 | Lower limb muscle weakness (HP:0007340) | 2.19629034 |
| 76 | Nephronophthisis (HP:0000090) | 2.17436544 |
| 77 | Hypsarrhythmia (HP:0002521) | 2.16983130 |
| 78 | Dysmetric saccades (HP:0000641) | 2.16714474 |
| 79 | Absent speech (HP:0001344) | 2.15614452 |
| 80 | Distal arthrogryposis (HP:0005684) | 2.15050288 |
| 81 | Stereotypic behavior (HP:0000733) | 2.14878619 |
| 82 | Type 1 muscle fiber predominance (HP:0003803) | 2.14312589 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.12468011 |
| 84 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.10066610 |
| 85 | True hermaphroditism (HP:0010459) | 2.07725312 |
| 86 | Congenital stationary night blindness (HP:0007642) | 2.04376282 |
| 87 | Craniofacial dystonia (HP:0012179) | 2.01272911 |
| 88 | Termporal pattern (HP:0011008) | 2.01265090 |
| 89 | Insidious onset (HP:0003587) | 2.01265090 |
| 90 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.00420020 |
| 91 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.00420020 |
| 92 | Medial flaring of the eyebrow (HP:0010747) | 1.99731815 |
| 93 | Protruding tongue (HP:0010808) | 1.97993741 |
| 94 | Pancreatic cysts (HP:0001737) | 1.96449361 |
| 95 | Incomplete penetrance (HP:0003829) | 1.96184401 |
| 96 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.95500714 |
| 97 | Neuronal loss in central nervous system (HP:0002529) | 1.92434704 |
| 98 | Gait ataxia (HP:0002066) | 1.92023962 |
| 99 | Sleep apnea (HP:0010535) | 1.91825091 |
| 100 | Annular pancreas (HP:0001734) | 1.91480959 |
| 101 | Pheochromocytoma (HP:0002666) | 1.91312339 |
| 102 | Delusions (HP:0000746) | 1.91191139 |
| 103 | Inability to walk (HP:0002540) | 1.88446480 |
| 104 | Hypoventilation (HP:0002791) | 1.88301416 |
| 105 | Abnormal EKG (HP:0003115) | 1.86874699 |
| 106 | Gait imbalance (HP:0002141) | 1.86458434 |
| 107 | Insomnia (HP:0100785) | 1.86314279 |
| 108 | Rigidity (HP:0002063) | 1.85579478 |
| 109 | Rapidly progressive (HP:0003678) | 1.82392625 |
| 110 | Abnormal ciliary motility (HP:0012262) | 1.82188512 |
| 111 | Vaginal atresia (HP:0000148) | 1.80576784 |
| 112 | Genital tract atresia (HP:0001827) | 1.79811754 |
| 113 | Pointed chin (HP:0000307) | 1.79686827 |
| 114 | Hyporeflexia of lower limbs (HP:0002600) | 1.78805334 |
| 115 | Central scotoma (HP:0000603) | 1.78680699 |
| 116 | Abnormal drinking behavior (HP:0030082) | 1.78452966 |
| 117 | Polydipsia (HP:0001959) | 1.78452966 |
| 118 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.76320474 |
| 119 | Absent/shortened dynein arms (HP:0200106) | 1.76320474 |
| 120 | Lower limb amyotrophy (HP:0007210) | 1.76213673 |
| 121 | Resting tremor (HP:0002322) | 1.75293362 |
| 122 | Specific learning disability (HP:0001328) | 1.75119880 |
| 123 | Clumsiness (HP:0002312) | 1.74332180 |
| 124 | Rimmed vacuoles (HP:0003805) | 1.74225401 |
| 125 | Hepatoblastoma (HP:0002884) | 1.74019251 |
| 126 | Bundle branch block (HP:0011710) | 1.73743924 |
| 127 | Hyperkalemia (HP:0002153) | 1.73528648 |
| 128 | Congenital primary aphakia (HP:0007707) | 1.72971501 |
| 129 | Agitation (HP:0000713) | 1.71260650 |
| 130 | Cutaneous finger syndactyly (HP:0010554) | 1.70972437 |
| 131 | Abnormality of the renal medulla (HP:0100957) | 1.69816930 |
| 132 | Type II lissencephaly (HP:0007260) | 1.69765361 |
| 133 | Blue irides (HP:0000635) | 1.69620718 |
| 134 | Clonus (HP:0002169) | 1.69590711 |
| 135 | Abnormality of saccadic eye movements (HP:0000570) | 1.69230739 |
| 136 | Psychosis (HP:0000709) | 1.68901214 |
| 137 | Difficulty running (HP:0009046) | 1.68728148 |
| 138 | Abnormality of salivation (HP:0100755) | 1.68326596 |
| 139 | Muscle fiber splitting (HP:0003555) | 1.68261971 |
| 140 | Neuroendocrine neoplasm (HP:0100634) | 1.67106949 |
| 141 | Calcaneovalgus deformity (HP:0001848) | 1.66851998 |
| 142 | Areflexia of lower limbs (HP:0002522) | 1.66796241 |
| 143 | Prolonged QT interval (HP:0001657) | 1.65688802 |
| 144 | Molar tooth sign on MRI (HP:0002419) | 1.65615728 |
| 145 | Abnormality of midbrain morphology (HP:0002418) | 1.65615728 |
| 146 | Frequent falls (HP:0002359) | 1.64796905 |
| 147 | Akinesia (HP:0002304) | 1.63445494 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.08128473 |
| 2 | NTRK3 | 4.34688754 |
| 3 | MAP3K9 | 3.59511613 |
| 4 | OBSCN | 3.25663875 |
| 5 | FRK | 3.01166068 |
| 6 | MAP3K4 | 2.99522322 |
| 7 | PRKD3 | 2.68191206 |
| 8 | DAPK2 | 2.65392520 |
| 9 | MINK1 | 2.61162022 |
| 10 | MAP2K7 | 2.46656826 |
| 11 | MARK1 | 2.42857329 |
| 12 | PAK6 | 2.38201205 |
| 13 | NTRK2 | 2.13712078 |
| 14 | KSR2 | 2.11675794 |
| 15 | MAP2K4 | 1.98710740 |
| 16 | MAP3K12 | 1.98115048 |
| 17 | CASK | 1.88426530 |
| 18 | CAMKK1 | 1.73871285 |
| 19 | RIPK4 | 1.72137894 |
| 20 | NTRK1 | 1.71031236 |
| 21 | PRPF4B | 1.65056330 |
| 22 | DAPK1 | 1.59011933 |
| 23 | STK38 | 1.56673838 |
| 24 | PLK2 | 1.52179127 |
| 25 | CDK5 | 1.50824127 |
| 26 | KSR1 | 1.49962542 |
| 27 | PHKG1 | 1.48632627 |
| 28 | PHKG2 | 1.48632627 |
| 29 | BMPR1B | 1.45347700 |
| 30 | TNIK | 1.45236457 |
| 31 | MAP3K13 | 1.42519592 |
| 32 | CDK19 | 1.42341609 |
| 33 | GRK5 | 1.41368669 |
| 34 | ARAF | 1.33345429 |
| 35 | DYRK2 | 1.28874591 |
| 36 | MAPK13 | 1.26259644 |
| 37 | PRKCG | 1.20660344 |
| 38 | LMTK2 | 1.11006797 |
| 39 | MKNK2 | 1.10882368 |
| 40 | SIK2 | 1.09024877 |
| 41 | TYRO3 | 1.06696264 |
| 42 | PINK1 | 1.03548489 |
| 43 | FES | 1.03520535 |
| 44 | MAP3K2 | 1.00755515 |
| 45 | PKN1 | 0.98922210 |
| 46 | CAMK2A | 0.98717251 |
| 47 | PTK2B | 0.96226542 |
| 48 | TAOK1 | 0.95258165 |
| 49 | LATS2 | 0.94903247 |
| 50 | CAMK1 | 0.94068955 |
| 51 | ADRBK2 | 0.91256469 |
| 52 | PRKCH | 0.89802315 |
| 53 | LATS1 | 0.89412300 |
| 54 | SGK494 | 0.88909765 |
| 55 | SGK223 | 0.88909765 |
| 56 | NME1 | 0.88789199 |
| 57 | INSRR | 0.87321656 |
| 58 | PNCK | 0.86645249 |
| 59 | CDK18 | 0.85718083 |
| 60 | CDK15 | 0.85487729 |
| 61 | FGFR2 | 0.84771536 |
| 62 | CAMKK2 | 0.83467632 |
| 63 | CDK14 | 0.79773321 |
| 64 | RAF1 | 0.78881477 |
| 65 | UHMK1 | 0.78540112 |
| 66 | STK11 | 0.77429687 |
| 67 | SGK2 | 0.76745164 |
| 68 | MAPK15 | 0.76730288 |
| 69 | PAK3 | 0.74215167 |
| 70 | NEK1 | 0.73373891 |
| 71 | GRK1 | 0.73291014 |
| 72 | ACVR1B | 0.73237501 |
| 73 | CDK11A | 0.72951801 |
| 74 | WNK4 | 0.72721623 |
| 75 | RET | 0.70581814 |
| 76 | MAP3K7 | 0.69694733 |
| 77 | CAMK2B | 0.69065898 |
| 78 | DYRK1A | 0.68298106 |
| 79 | SGK1 | 0.67532082 |
| 80 | SGK3 | 0.66946039 |
| 81 | TNK2 | 0.66294410 |
| 82 | STK38L | 0.64466320 |
| 83 | OXSR1 | 0.63625491 |
| 84 | BMPR2 | 0.63443456 |
| 85 | PDK1 | 0.63303750 |
| 86 | ZAK | 0.62044464 |
| 87 | MAP4K2 | 0.61335453 |
| 88 | RIPK1 | 0.59901664 |
| 89 | PRKG1 | 0.59118797 |
| 90 | MUSK | 0.59022024 |
| 91 | PDPK1 | 0.57684411 |
| 92 | NUAK1 | 0.56812286 |
| 93 | ALK | 0.56429678 |
| 94 | MAP2K6 | 0.55268900 |
| 95 | MARK2 | 0.54792500 |
| 96 | MAP3K1 | 0.54384082 |
| 97 | MAPKAPK5 | 0.53615498 |
| 98 | PRKAA1 | 0.52798993 |
| 99 | CSNK1G1 | 0.50901665 |
| 100 | FGR | 0.50013942 |
| 101 | RPS6KA3 | 0.48981591 |
| 102 | MAPK12 | 0.48500770 |
| 103 | PRKACA | 0.47777555 |
| 104 | FER | 0.47718014 |
| 105 | STK39 | 0.47508251 |
| 106 | CAMK2G | 0.47417606 |
| 107 | CSNK1G2 | 0.47261422 |
| 108 | PRKCE | 0.46837395 |
| 109 | CAMK1G | 0.46088409 |
| 110 | CSNK1D | 0.45669177 |
| 111 | CAMK2D | 0.44151593 |
| 112 | ERBB2 | 0.43048104 |
| 113 | NEK6 | 0.42822615 |
| 114 | DDR2 | 0.42656506 |
| 115 | MAPK10 | 0.42563029 |
| 116 | PRKCZ | 0.42215291 |
| 117 | MAP2K1 | 0.42177373 |
| 118 | MAP3K6 | 0.42021666 |
| 119 | CCNB1 | 0.41871214 |
| 120 | CAMK1D | 0.41841760 |
| 121 | CAMK4 | 0.41372459 |
| 122 | CSNK1G3 | 0.40472400 |
| 123 | WNK3 | 0.39979504 |
| 124 | CDC42BPA | 0.39819570 |
| 125 | DMPK | 0.39736626 |
| 126 | DAPK3 | 0.39139744 |
| 127 | CSNK1A1 | 0.38263411 |
| 128 | MAP3K11 | 0.38008303 |
| 129 | PIK3CA | 0.37829698 |
| 130 | CSNK1A1L | 0.37617172 |
| 131 | CSNK1E | 0.37431637 |
| 132 | ADRBK1 | 0.36992742 |
| 133 | FYN | 0.36531258 |
| 134 | TAOK2 | 0.31160031 |
| 135 | ROCK2 | 0.30524514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.72295137 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.43370260 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.81566314 |
| 4 | * GABAergic synapse_Homo sapiens_hsa04727 | 2.67873336 |
| 5 | * Circadian entrainment_Homo sapiens_hsa04713 | 2.66029938 |
| 6 | * Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.59500455 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.56440314 |
| 8 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.54936615 |
| 9 | * Morphine addiction_Homo sapiens_hsa05032 | 2.40801103 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38742925 |
| 11 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.23263988 |
| 12 | * Salivary secretion_Homo sapiens_hsa04970 | 2.17914348 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.05050070 |
| 14 | * Insulin secretion_Homo sapiens_hsa04911 | 2.01809217 |
| 15 | * Gastric acid secretion_Homo sapiens_hsa04971 | 1.89357551 |
| 16 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.82172279 |
| 17 | Renin secretion_Homo sapiens_hsa04924 | 1.73685663 |
| 18 | * Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.70640843 |
| 19 | * Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.67318040 |
| 20 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.66925464 |
| 21 | Taste transduction_Homo sapiens_hsa04742 | 1.65404933 |
| 22 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61441409 |
| 23 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.61369723 |
| 24 | Long-term depression_Homo sapiens_hsa04730 | 1.59738711 |
| 25 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59257813 |
| 26 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.54349868 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.53727012 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.51269648 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.41878779 |
| 30 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.39178571 |
| 31 | * GnRH signaling pathway_Homo sapiens_hsa04912 | 1.38169400 |
| 32 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 1.25314904 |
| 33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.25262105 |
| 34 | * Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.23826725 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.23033118 |
| 36 | * Gap junction_Homo sapiens_hsa04540 | 1.19386189 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.16999136 |
| 38 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13165058 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.12964289 |
| 40 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.10093770 |
| 41 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.07135224 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04892852 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.04478453 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.03755485 |
| 45 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03108230 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 1.01982994 |
| 47 | * Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.99890108 |
| 48 | Histidine metabolism_Homo sapiens_hsa00340 | 0.99531293 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98778780 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96676315 |
| 51 | * Melanogenesis_Homo sapiens_hsa04916 | 0.95117825 |
| 52 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93541066 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.92894133 |
| 54 | * Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86562533 |
| 55 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.85907305 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.85586632 |
| 57 | * Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84450170 |
| 58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83724190 |
| 59 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79098022 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77936275 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.77092142 |
| 62 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76934917 |
| 63 | * Pancreatic secretion_Homo sapiens_hsa04972 | 0.76118277 |
| 64 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.75147748 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72583078 |
| 66 | * Oocyte meiosis_Homo sapiens_hsa04114 | 0.72372367 |
| 67 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.72121827 |
| 68 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69176044 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69003236 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68258369 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.66807996 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.66562365 |
| 73 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65839428 |
| 74 | * Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63591841 |
| 75 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63264852 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.61378764 |
| 77 | * Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60358439 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60093412 |
| 79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59816201 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.59077245 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.58867827 |
| 82 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57149185 |
| 83 | ABC transporters_Homo sapiens_hsa02010 | 0.56906379 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56736737 |
| 85 | * Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55832079 |
| 86 | Parkinsons disease_Homo sapiens_hsa05012 | 0.54558207 |
| 87 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.54483667 |
| 88 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.53443928 |
| 89 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51725477 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.51033629 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50745305 |
| 92 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49931754 |
| 93 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.48911769 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.48787944 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.48751700 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48544185 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.48025118 |
| 98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46818850 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.46651453 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.46593363 |
| 101 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.45962869 |
| 102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45250803 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.45107779 |
| 104 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44617992 |
| 105 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44273668 |
| 106 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.43583828 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.43551267 |
| 108 | Alcoholism_Homo sapiens_hsa05034 | 0.43398687 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43105434 |
| 110 | * Bile secretion_Homo sapiens_hsa04976 | 0.42529692 |
| 111 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41871602 |
| 112 | Prion diseases_Homo sapiens_hsa05020 | 0.40906101 |
| 113 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40728765 |
| 114 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.39883824 |
| 115 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38996030 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.36861198 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36831897 |
| 118 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.34727820 |
| 119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.34448789 |
| 120 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34190909 |
| 121 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33678682 |
| 122 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31244647 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.31226556 |
| 124 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30166046 |
| 125 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.28526912 |
| 126 | Alzheimers disease_Homo sapiens_hsa05010 | 0.27109348 |
| 127 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.25462435 |
| 128 | * Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24650360 |
| 129 | * Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.24382684 |
| 130 | Mineral absorption_Homo sapiens_hsa04978 | 0.22347478 |

